Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-18T21:53:32.080Z Has data issue: false hasContentIssue false
  • English
  • Français

Risperidone in schizophrenia

Published online by Cambridge University Press:  02 January 2018

S. Bazire
S. Bazire*
Affiliation:
Hellesdon Hospital, Norwich NR6 5BE
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 168 , Issue 1 , January 1996 , pp. 128
Copyright
Copyright © 1996 The Royal College of Psychiatrists 

References

Liberman, R. P., Van Putten, T., Marshall, B. D. Jr., et al (1994) Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. American Journal of Psychiatry, 151, 756–759.Google ScholarPubMed
Peukens, J., for the Risperidone Study Group (1995) Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. British Journal of Psychiatry, 166, 712–726.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.